In a COVID-19 pandemic, a neurologist needs to be able to assess the risks of virus infection in patients with individual neurological diseases. The review presents categories of risk groups from the Association of British Neurologists for neuromuscular diseases, multiple sclerosis and other autoimmune diseases of the central nervous system, stroke, epilepsy and Parkinson’s disease. The risk of infection and the management of patients with neuromuscular diseases are analyzed in detail. The use of multiple sclerosis disease modifying drugs, the treatment of stroke patients are discussed. The data from the international guidelines for the management of patients with epilepsy and Parkinson’s disease are presented.
Aim - studying of quality of life of the patients with multiple sclerosis receiving the medicines changing the course of multiple sclerosis, the first and second line for identification of the most optimum methods of therapy of a disease. Materials and methods. Survey of 100 patients aged from 18 up to 65 years receiving medicines of the first and second line by means of a scale of hospital alarm and a depression of HADS and the questionnaire of quality of life of SF-36 is conducted. Results. The obtained data have shown that medicines of the second line authentically raise physical and social indicators of quality of life; in addition, the interrelation between an emotional condition of the patient and degree of his social activity is found. Conclusion. It is established that the alarm and a depression significantly limit physical activity of the patient, reduce independent assessment by the patient of a condition of the health and quality of life of patients. It is necessary to estimate the level of alarm and a depression at patients with multiple sclerosis and to correct the phenomena of emotional instability as they influence physical health, social contacts, level of pain and, as a result, quality of life.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.